Testing Laboratories - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Testing Laboratories - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Testing Laboratories
Corporate Insider Buy Sell Ratio (Insider Count) - Testing Laboratories
Testing Laboratories - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2021-06-02 NEO / NeoGenomics, Inc. 4 CROWTHER BRUCE K A - Award D 3,714
2021-06-02 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE S - Sale D 40.39 -169,230
2021-05-25 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D 28.33 14,067
2021-05-25 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D 19.60 16,724
2021-05-25 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D 8.03 96,167
2021-05-25 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D -16,724
2021-05-25 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D -14,067
2021-05-25 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D -96,167
2021-05-25 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. S - Sale D 39.31 -130,604
2021-04-22 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D -6,667
2021-04-22 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D -9,005
2021-04-22 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D 9.22 6,667
2021-04-22 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D 19.60 9,005
2021-04-22 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D 28.33 9,378
2021-04-22 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin M - Exercise D -9,378
2021-04-19 NEO / NeoGenomics, Inc. 4 Mallon Mark A - Award D 55,736
2021-04-19 NEO / NeoGenomics, Inc. 4 Mallon Mark A - Award D 151,016
2021-03-25 DIGP / Hypha Labs, Inc. 4 Peterson Todd A A - Award D 266,430
2021-03-25 DIGP / Hypha Labs, Inc. 4 RABEN BRUCE I A - Award D 200,000
2021-03-25 DIGP / Hypha Labs, Inc. 4 DeFrank Edmond A - Award D 200,000
2021-03-25 DIGP / Hypha Labs, Inc. 4 Hartmann Dennis A - Award D 200,000
2021-03-10 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L S - Sale D 8.43 -11,999
2021-03-10 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L S - Sale D 8.47 -210
2021-03-10 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L S - Sale D 8.45 -610
2021-03-10 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L S - Sale D 8.51 -201
2021-03-10 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L S - Sale D 8.52 -29
2021-03-05 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L M - Exercise D 4.43 3,832
2021-03-05 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L M - Exercise D 4.26 9,217
2021-03-05 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L M - Exercise D -20,834
2021-03-05 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L M - Exercise D -9,121
2021-03-02 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER F - Taxes D -173
2021-03-02 NEO / NeoGenomics, Inc. 4 Bonello William F - Taxes D -432
2021-03-02 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B F - Taxes D -432
2021-03-02 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M F - Taxes D -2,158
2021-03-02 NEO / NeoGenomics, Inc. 4 Pedulla Denise E F - Taxes D -216
2021-03-02 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. F - Taxes D -608
2021-03-02 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M A - Award D 56,423
2021-03-02 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. A - Award D 6,827
2021-03-02 NEO / NeoGenomics, Inc. 4 Pedulla Denise E A - Award D 53.17 24,619
2021-03-02 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B A - Award D 53.17 35,171
2021-03-02 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin A - Award D 53.17 29,895
2021-03-02 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin A - Award D 5,276
2021-03-02 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. A - Award D 53.17 38,688
2021-03-02 NEO / NeoGenomics, Inc. 4 Pedulla Denise E A - Award D 4,345
2021-03-02 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B A - Award D 6,207
2021-03-02 NEO / NeoGenomics, Inc. 4 Dieter Cynthia J A - Award D 1,241
2021-03-02 NEO / NeoGenomics, Inc. 4 Dieter Cynthia J A - Award D 53.17 7,034
2021-03-02 NEO / NeoGenomics, Inc. 4 Brown Douglas Matthew A - Award D 53.17 26,378
2021-03-02 NEO / NeoGenomics, Inc. 4 Brown Douglas Matthew A - Award D 4,655
2021-03-02 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER A - Award D 53.17 10,551
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)